Clinical trial / 2013
Seaweed supplementation temporarily decreased urinary uPAR concentrations by about half in postmenopausal women.
In a 3-month trial, 15 postmenopausal women took 5 g daily of placebo for 4 weeks, seaweed (Undaria) for 4 weeks, and placebo for another 4 weeks. Urinary creatinine-standardized uPAR decreased significantly during seaweed intake (placebo 1: 1.5 [95% CI, 0.9-2.1]; seaweed: 0.9 [95% CI, 0.6-1.1]; placebo 2: 1.7 [95% CI, 1.2-2.2]; p = 0.01). A urinary protein (m/z 9,776) showed a similar reversible decrease, while a serum protein (m/z 8,928) reversibly increased.
- Study type
- Single-blind placebo-controlled crossover trial
- Who was studied
- 15 healthy postmenopausal American women (5 controls, 10 breast cancer survivors)
- What was measured
- Urinary urokinase-type plasminogen activator receptor (uPAR) and protein expression
THE PAPER
The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle.
Teas J, Vena S, Cone DL, Irhimeh M. J Appl Phycol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.